Clinical Trial Update: DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating DHEA bioavailability after vaginal suppositories in postmenopausal women with vaginal atrophy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy

Drugs mentioned

• DHEA vaginal suppositories (dehydroepiandrosterone)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Vaginal Atrophy | Phase 1 | Status: COMPLETED